{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T03:37:04Z","timestamp":1784000224010,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T00:00:00Z","timestamp":1642723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s12640-021-00468-1","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T05:31:54Z","timestamp":1642743114000},"page":"636-645","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Nanotechnology in Improving the Treatment of Huntington\u2019s Disease: a Systematic Review"],"prefix":"10.1007","volume":"40","author":[{"given":"Kesllin Mariane Gomes","family":"Valad\u00e3o","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara Okabaiasse","family":"Luizeti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian Ueda","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina","family":"Issy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2201-5978","authenticated-orcid":false,"given":"Marcelo Picinin","family":"Bernuci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,21]]},"reference":[{"key":"468_CR1","doi-asserted-by":"crossref","unstructured":"Abhayraj SJ, Thakur AK (2014) Biodegradable delivery system containing a peptide inhibitor of polyglutamine aggregation: a step toward therapeutic development in Huntington\u2019s disease. J Pept Sci 630\u2013639","DOI":"10.1002\/psc.2640"},{"issue":"7","key":"468_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/adhm.202001736","volume":"10","author":"A Adhikari","year":"2021","unstructured":"Adhikari A, Mondal S, Das M, Biswas P, Pal U, Darbar S, Bhattacharya SS, Pal D, Saha-Dasgupta T, Das AK, Mallick AK, Pal SK (2021) Incorporation of a biocompatible nanozyme in cellular antioxidant enzyme cascade reverses Huntington\u2019s like disorder in preclinical model. Adv Healthc Mater 10(7):1\u201313","journal-title":"Adv Healthc Mater"},{"key":"468_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.molliq.2016.11.064","volume":"235","author":"B Angelov","year":"2017","unstructured":"Angelov B, Garamus VM, Drechsler M, Angelova A (2017) Structural analysis of nanoparticulate carriers for encapsulation of macromolecular drugs. J Mol Liq 235:83\u201389","journal-title":"J Mol Liq"},{"issue":"6","key":"468_CR4","doi-asserted-by":"publisher","first-page":"886","DOI":"10.4103\/1673-5374.208546","volume":"12","author":"A Angelova","year":"2017","unstructured":"Angelova A, Angelov B (2017) Dual and multi-drug delivery nanoparticles towards neuronal survival and synaptic repair. Neural Regen Res 12(6):886\u2013889","journal-title":"Neural Regen Res"},{"key":"468_CR5","doi-asserted-by":"publisher","DOI":"10.1242\/dmm.041319","author":"T Ardan","year":"2019","unstructured":"Ardan T et al (2019) Transgenic minipig model of Huntington\u2019s disease exhibiting gradually progressing neurodegeneration. Dis Model Mech. https:\/\/doi.org\/10.1242\/dmm.041319","journal-title":"Dis Model Mech"},{"issue":"1\u20132","key":"468_CR6","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.ijpharm.2018.03.061","volume":"543","author":"D Belletti","year":"2018","unstructured":"Belletti D, Grabrucker AM, Pederzoli F, Menrath I, Vandelli MA, Tosi G, Duskey TJ, Thomas J, Forni F, Ruozi B (2018) Hybrid nanoparticles as a new technological approach to enhance the delivery of cholesterol into the brain. Int J Pharm 543(1\u20132):300\u2013310","journal-title":"Int J Pharm"},{"key":"468_CR7","doi-asserted-by":"crossref","unstructured":"Belletti D, Grabrucker AM, Pederzoli F, Menrath I, Cappello V, Vandelli MA, Forni F, Tosi G, Ruozi B (2016) Exploiting the versatility of cholesterol in nanoparticles formulation. Int J Pharm 1\u201310","DOI":"10.1016\/j.ijpharm.2016.07.022"},{"issue":"7","key":"468_CR8","doi-asserted-by":"publisher","first-page":"931","DOI":"10.3109\/10717544.2014.880860","volume":"22","author":"R Bhatt","year":"2015","unstructured":"Bhatt R, Singh D, Prakash A, Mishra N (2015) Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington\u2019s disease. Drug Delivery 22(7):931\u2013939","journal-title":"Drug Delivery"},{"issue":"330","key":"468_CR9","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.jconrel.2020.12.051","volume":"10","author":"G Birolini","year":"2021","unstructured":"Birolini G, Valenza M, Ottonelli I, Passoni A, Favagrossa M, Duskey JT, Bombaci M, Vandelli MA, Colombo L, Bagnati R, Caccia C, Leoni V, Taroni F, Forni F, Ruozi B, Salmona M, Tosi G, Cattaneo E (2021) Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington\u2019s disease. J Control Release 10(330):587\u2013598","journal-title":"J Control Release"},{"issue":"1","key":"468_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2217\/nnm-2020-0239","volume":"16","author":"A Cano","year":"2021","unstructured":"Cano A, Ettcheto M, Espina M, Auladell C, Folch J, K\u00fchne BA, Barenys M, S\u00e1nchez-L\u00f3pez E, Souto EB, Garc\u00eda ML, Turowski P, Camins A (2021) Epigallocatechin-3-gallate PEGylated poly(lactic-co-glycolic) acid nanoparticles mitigate striatal pathology and motor deficits in 3-nitropropionic acid intoxicated mice. Nanomedicine 16(1):19\u201335","journal-title":"Nanomedicine"},{"issue":"6","key":"468_CR11","first-page":"2223","volume":"44","author":"M Carbo","year":"2019","unstructured":"Carbo M, Brandi V, Pascarella G, Staid DS, Colotti G, Polticelli F, Llari A, Morea V (2019) Bioinformatics analysis of Ras homologue enriched in the striatum, a potential target for Huntington\u2019s disease therapy. Int J Mol Med 44(6):2223\u20132233","journal-title":"Int J Mol Med"},{"key":"468_CR12","doi-asserted-by":"crossref","unstructured":"Cariulo C, Verani M, Martufi P, Ingenito R, Finotto M, Deguire SM, Lavery DJ, Toledo-Sherman L, Lee R, Doherty EM, Vogt TF, Dominguez C, Lashuel HA, Petricca L, Caricasole A (2019) Ultrasensitive quantitative measurement of huntingtin phosphorylation at residue S13. Biochem Biophys Res Commun","DOI":"10.1016\/j.bbrc.2019.09.097"},{"key":"468_CR13","doi-asserted-by":"crossref","unstructured":"Caron NS, Dorsey ER, Hayden MR (2018) Therapeutic approaches to Huntington disease: from the bench to the clinic. Nat Rev Drug Discov 17(10):729750","DOI":"10.1038\/nrd.2018.133"},{"key":"468_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.bbr.2018.12.040","volume":"361","author":"W Chen","year":"2019","unstructured":"Chen W, Zhang S, Turel O, Peng Y, Chen H, He Q (2019) Sex-based differences in right dorsolateral prefrontal cortex roles in fairness norm compliance. Behav Brain Res 361:104\u2013112","journal-title":"Behav Brain Res"},{"key":"468_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino L, Bisogno T, Di Marzo V (2020) Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol 16:9\u201329","journal-title":"Nat Rev Neurol"},{"key":"468_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.nbd.2018.08.010","volume":"122","author":"KR Croce","year":"2019","unstructured":"Croce KR, Yamamoto AI (2019) A role for autophagy in Huntington\u2019s disease. Neurobiol Dis 122:16\u201322","journal-title":"Neurobiol Dis"},{"issue":"28","key":"468_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/acsami.7b06510","volume":"9","author":"K Debnath","year":"2017","unstructured":"Debnath K, Pradhan N, Singh BK, Jana NR (2017) Poly(trehalose) Nanoparticles prevent amyloid aggregation and suppress polyglutamine aggregation in a Huntington\u2019s disease model mouse. ACS Appl Mater Interfaces 9(28):1\u201346","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"468_CR18","first-page":"431433","volume":"8","author":"ST Debot","year":"2019","unstructured":"Debot ST (2019) Raising awareness of therapeutic misconception and optimism around clinical trials in Huntington\u2019s disease. J Huntingtons Dis 8(4):431433","journal-title":"J Huntingtons Dis"},{"issue":"4","key":"468_CR19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1002\/ajmg.a.38494","volume":"176","author":"AS Dickey","year":"2017","unstructured":"Dickey AS, La Spada AR (2017) Therapy development in Huntington disease: From current strategies to emerging opportunities. Am J Med Genet A 176(4):842\u2013861","journal-title":"Am J Med Genet A"},{"issue":"10","key":"468_CR20","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/mt.2016.126","volume":"24","author":"M Didiot","year":"2016","unstructured":"Didiot M, Hall LM, Coles AH, Haraszti RA, Godinho BM, Chase K, Ly S, Alterman JF, Hassler MR, Echeverria D, Raj L, Morrissey DV, DiFiglia M, Aronin N, Khvorova A (2016) Exosome-mediated delivery of hydrophobically modified siRNA for Huntingtin mRNA silencing. Mol Ther 24(10):1836\u20131847","journal-title":"Mol Ther"},{"issue":"1","key":"468_CR21","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1080\/21688370.2016.1153568","volume":"4","author":"AM Grabrucker","year":"2016","unstructured":"Grabrucker AM, Ruozi B, Belletti D, Pederzoli F, Forni F, Vandelli MA, Tosi G (2016) Nanoparticle transport across the blood brain barrier. Tissue Barriers 4(1):171","journal-title":"Tissue Barriers"},{"issue":"2","key":"468_CR22","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s11095-016-2080-4","volume":"34","author":"LPB Guerzoni","year":"2016","unstructured":"Guerzoni LPB, Nicolas VAA (2016) In vitro modulation of TrkB receptor signaling upon sequential delivery of curcumin-DHA loaded carriers towards promoting neuronal survival. Pharm Res 34(2):492\u2013505","journal-title":"Pharm Res"},{"issue":"11","key":"468_CR23","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1001\/archneur.1993.00540110037003","volume":"50","author":"JF Gusella","year":"1993","unstructured":"Gusella JF, MacDonald ME, Ambrose CM, Duyao MP (1993) Molecular genetics of Huntington\u2019s disease. Arch Neurol 50(11):1157\u20131163","journal-title":"Arch Neurol"},{"key":"468_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.lfs.2017.06.001","volume":"182","author":"P Hassanzadh","year":"2017","unstructured":"Hassanzadh P, Atybi F, Dinarvand R (2017) Application of modelling and nanotechnology-based approaches: the emergence of breakthroughs in the diagnostics of central nervous system disorders. Life Sci 182:93\u2013103","journal-title":"Life Sci"},{"issue":"1","key":"468_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s41181-019-0071-6.P","volume":"4","author":"T Huhtala","year":"2019","unstructured":"Huhtala T, Poutiainen P, Rytk\u00f6nen J, Lehtim\u00e4ki K, Parkkari T, Kasanen I, Airaksinen AJ, Koivula T, Sweeney P, Kontkanen O, Wityak J, Dominiquez C, Park LC (2019) Improved synthesis of [18F] fallypride and characterization of a Huntington\u2019s disease mouse model, zQ175DN KI, using longitudinal PET imaging of D2\/D3 receptors. EJNMMI Radiopharm Chem 4(1):20. https:\/\/doi.org\/10.1186\/s41181-019-0071-6.P","journal-title":"EJNMMI Radiopharm Chem"},{"issue":"11","key":"468_CR26","doi-asserted-by":"publisher","first-page":"e0224633","DOI":"10.1371\/journal.pone.0224633","volume":"14","author":"DS Jonesco","year":"2019","unstructured":"Jonesco DS, Hassager C, Frydland M, Kjaergaard J, Karsdal M, Henriksen K (2019) A caspase-6-cleaved fragment of glial fibrillary acidic protein as a potential serological biomarker of CNS injury after cardiac arrest. PLoS One 14(11):e0224633. https:\/\/doi.org\/10.1371\/journal.pone.0224633","journal-title":"PLoS ONE"},{"issue":"1","key":"468_CR27","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s40580-018-0168-8","volume":"5","author":"YJ Kang","year":"2018","unstructured":"Kang YJ, Cutler EG, Cho H (2018) Therapeutic nanoplatforms and delivery strategies for neurological disorders. Nano Converg 5(1):35. https:\/\/doi.org\/10.1186\/s40580-018-0168-8","journal-title":"Nano Converg"},{"key":"468_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/B978-0-12-801893-4.00003-1","volume":"144","author":"C Kay","year":"2017","unstructured":"Kay C, Hayden MR, Leavitt BR (2017) Epidemiology of Huntington disease. Handb Clin Neurol 144:31\u201346","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"468_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334","journal-title":"Eur J Neurol"},{"key":"468_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.progpolymsci.2016.09.006","volume":"64","author":"S Mignani","year":"2017","unstructured":"Mignani S, Bryszewska M, Zablocka M, Klanjnert-Maculewicz B, Cladera J, Shcharbin D, Majoral J (2017) Can dendrimer based nanoparticles fight neurodegenerative diseases? Current situation versus other established approaches. Prog Polym Sci 64:23\u201351","journal-title":"Prog Polym Sci"},{"issue":"36","key":"468_CR31","doi-asserted-by":"publisher","first-page":"16962","DOI":"10.1039\/C8NR04073G","volume":"10","author":"N Poovaiah","year":"2018","unstructured":"Poovaiah N, Davoudi Z, Peng H, Schlichtmann B, Mallapgragada S, Narasimhan B, Wang Q (2018) Treatment of neurodegenerative disorders through the blood\u2013brain barrier using nanocarriers. Nanoscale 10(36):16962\u201316983","journal-title":"Nanoscale"},{"issue":"5","key":"468_CR32","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s11011-018-0252-0","volume":"33","author":"S Ramachandran","year":"2018","unstructured":"Ramachandran S, Thangarajan S (2018) Thymoquinone loaded solid lipid nanoparticles counteracts 3-nitropropionic acid induced motor impairments and neuroinflammation in rat model of Huntington\u2019s disease. Metab Brain Dis 33(5):1459\u20131470","journal-title":"Metab Brain Dis"},{"key":"468_CR33","doi-asserted-by":"publisher","first-page":"5561","DOI":"10.2147\/IJN.S149022","volume":"13","author":"S Ramanathan","year":"2018","unstructured":"Ramanathan S, Archunan G, Sivakumar M, Selvan ST, Fred AL, Kumar S, Guly\u00e1s B, Padmanabhan P (2018) Theranostic applications of nanoparticles in neurodegenerative disorders. Int J Nanomed 13:5561\u20135576","journal-title":"Int J Nanomed"},{"key":"468_CR34","doi-asserted-by":"crossref","unstructured":"Ringkobing SP, Larsen IU, Jorgensen K, Vinther-Jensen T, Vogel A (2019) Cognitive screening tests in Huntington gene mutation carriers: examining the validity of the mini mental state examination and the Montreal Cognitive Assessment. J Huntingtons Dis 1\u201310","DOI":"10.3233\/JHD-190350"},{"issue":"40","key":"468_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-1172-5-40","volume":"5","author":"RAC Roos","year":"2010","unstructured":"Roos RAC (2010) Huntington\u2018s disease: a clinical review. Orphanet J Rare Dis 5(40):1\u20138. https:\/\/doi.org\/10.1186\/1750-1172-5-40","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"468_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/brb3.1196","volume":"9","author":"R Silberstein","year":"2019","unstructured":"Silberstein R, Camfield DA, Nield G, Stough C (2019) Gender differences in parietofrontal brain functional connectivity correlates of creativity. Brain Behav 9(2):1\u201310","journal-title":"Brain Behav"},{"issue":"3","key":"468_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/pharmaceutics11030101","volume":"11","author":"DM Teleanu","year":"2019","unstructured":"Teleanu DM, Chircov C, Grumezescu AM, Teleanu RI (2019) Neuronanomedicine: an up-to-date overview. Pharmaceutics 11(3):101\u2013115","journal-title":"Pharmaceutics"},{"issue":"11","key":"468_CR38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/nrd4333","volume":"13","author":"VP Torchilin","year":"2014","unstructured":"Torchilin VP (2014) Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery. Nat Rev Drug Discov 13(11):813\u2013827","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"468_CR39","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.15252\/emmm.201505413","volume":"7","author":"M Valenza","year":"2015","unstructured":"Valenza M, Chen JY, Di Paolo E, Ruozi B, Belletti D, Ferrari Bardile C, Leoni V, Caccia C, Brilli E, Di Donato S, Boido MM, Vercelli A, Vandelli MA, Forni F, Cepeda C, Levine MS, Tosi G, Cattaneo E (2015) Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington\u2019s disease mice. EMBO Mol Med 7(12):1547\u20131564. https:\/\/doi.org\/10.15252\/emmm.201505413","journal-title":"EMBO Mol Med"},{"key":"468_CR40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/B978-0-444-52014-2.00004-5","volume":"100","author":"JP Vonsattel","year":"2011","unstructured":"Vonsattel JP, Keller C, Cortes Ramirez EP (2011) Huntington\u2019s disease \u2014 neuropathology. Handb Clin Neurol 100:83\u2013100","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"468_CR41","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.biomaterials.2013.10.024","volume":"35","author":"PF Wei","year":"2013","unstructured":"Wei PF, Zhang L, Nethi SK, Barui AK, Lin J, Zhou W, Shen Y, Man N, Zhang YJ, Xu J, Patra CR, Wen LP (2013) Accelerating the clearance of mutant huntingtin protein aggregates through autophagy induction by europium hydroxide nanorods. Biomaterials 35(3):899\u2013907. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.10.024","journal-title":"Biomaterials"},{"key":"468_CR42","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jclinepi.2015.09.001","volume":"70","author":"V Welch","year":"2016","unstructured":"Welch V, Petticrew M, Petkovic J, Moher D, Waters E, White H, Tugwell P (2016) Extending the PRISMA statement to equity-focused systematic reviews (PRISMA-E 2012): explanation and elaboration. J Clin Epidemiol 70:68\u201389","journal-title":"J Clin Epidemiol"},{"issue":"33","key":"468_CR43","doi-asserted-by":"publisher","first-page":"8770","DOI":"10.1016\/j.biomaterials.2010.07.077","volume":"31","author":"Y Wong","year":"2010","unstructured":"Wong Y, Markham K, Xu ZP, Chen M, Max Lu GQ, Barlett PF, Cooper HM (2010) Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles. Biomaterials 31(33):8770\u20138779","journal-title":"Biomaterials"},{"issue":"11","key":"468_CR44","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/S1474-4422(20)30343-4","volume":"19","author":"GEB Wright","year":"2020","unstructured":"Wright GEB, Black HF, Collins JA, Terence G-D, Caron NS, Pearson CE, Hayden MR (2020) Interrupting sequence variants and age of onset in Huntington\u2019s disease: clinical implications and emerging therapies. Lancet Neurol 19(11):930\u2013939","journal-title":"Lancet Neurol"},{"key":"468_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.01.041","volume":"216","author":"L Zhang","year":"2019","unstructured":"Zhang L, Wei PF, Song YH, Dong L, Wu YD, Hao ZY, Fan S, Tai S, Meng JL, Lu Y, Xue J, Liang CZ, Wen LP (2019) MnFe2O4 nanoparticles accelerate the clearance of mutant huntingtin selectively through ubiquitin-proteasome system. Biomaterials 216:1\u201315","journal-title":"Biomaterials"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00468-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-021-00468-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-021-00468-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T04:59:02Z","timestamp":1650689942000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-021-00468-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["468"],"URL":"https:\/\/doi.org\/10.1007\/s12640-021-00468-1","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]},"assertion":[{"value":"6 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}